Paul Fréneaux

Université Paris Sciences et Lettres — France

Biochemistry, Genetics and Molecular Biology · Life Sciences

19h-index2.0kcitations49works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chromatin Remodeling and Cancer(20), Cancer Mechanisms and Therapy(17), Breast Cancer Treatment Studies(7), Sarcoma Diagnosis and Treatment(7), HER2/EGFR in Cancer Research(5)

Publications49 total

<scp> <i>SMARCB1</i> </scp> ‐deficient malignant melanocytic uveal tumours: a new neural crest‐derived tumour entity with <scp> <i>SMARCB1</i> </scp> ‐related germline predisposition
The Journal of Pathology·2025· 2 citedOpen Access
Imaging characterization of paediatric tumours with the <i>neurotrophic tyrosine receptor kinase</i> fusion transcript
British Journal of Radiology·2024· 2 citedOpen Access
Diffuse Infiltrating Retinoblastoma with Anterior Chamber Involvement: Conservative Management and Identification of RB1 Alterations in Aqueous Humor
Ocular Oncology and Pathology·2023· 4 citedOpen Access
NUT carcinoma in children, adolescents and young adults
Bulletin du Cancer·2022· 7 cited
<scp>SMARCA4</scp> ‐deficient rhabdoid tumours show intermediate molecular features between <scp>SMARCB1</scp> ‐deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type
The Journal of Pathology·2021· 24 cited
Esthesioneuroblastoma in children, adolescents and young adults
Bulletin du Cancer·2020· 10 citedOpen Access
Abstract B68: Spatial and temporal conditions for Smarcb1 deletion determines mouse AT/RT (atypical teratoid/rhabdoid tumor) subtype
Cancer Research·2020
Pattern of loco‐regional relapses and treatment in pediatric esthesioneuroblastoma: The French very rare tumors group (<i>Fracture</i>) contribution
Pediatric Blood & Cancer·2020· 13 cited
Pediatric Patient With Renal Cell Carcinoma Treated by Successive Antiangiogenics Drugs: A Case Report and Review of the Literature
Journal of Pediatric Hematology/Oncology·2017· 5 cited
Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers
Oncotarget·2017· 16 citedOpen Access
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma
Nature Medicine·2017· 254 citedOpen Access
Rhabdoid component emerging as a subclonal evolution of paediatric glioneuronal tumours
Neuropathology and Applied Neurobiology·2017· 7 cited
HSNF5/INI1/SMARCB1 Tumor Suppressor Gene
2017
Society News
Ocular Oncology and Pathology·2017
Conjunctival Melanoma in a Black Patient
JAMA Ophthalmology·2016· 2 cited
LG-32RHABDOID COMPONENT EMERGING AS A SUBCLONAL EVOLUTION OF PEDIATRIC GLIONEURONAL TUMORS
Neuro-Oncology·2016Open Access
The occurrence of intracranial rhabdoid tumours in mice depends on temporal control of Smarcb1 inactivation
Nature Communications·2016· 118 citedOpen Access
<i>SMARCA4</i>-Mutated Atypical Teratoid/Rhabdoid Tumor with Retained BRG1 Expression
Pediatric Blood & Cancer·2015· 21 cited
HSNF5/INI1/SMARCB1 Tumor Suppressor Gene
2015
Schwannomatosis Following an Early Rhabdoid Tumour of the Kidney: The Two Conditions May Coincide
Cancer Genetics·2014
page 1 of 3Next →

Frequent Co-authors

Olivier Delattre(21), Franck Bourdeaut(20), Gaëlle Pierron(18), Daniel Orbach(13), Anne Vincent‐Salomon(10), Hervé J. Brisse(9), Xavier Sastre‐Garau(8), Julien Masliah‐Planchon(8), Michael C. Frühwald(8), Nicolás André(7), Brigitte Sigal‐Zafrani(6), Martin Hasselblatt(6), Jean Michon(5), Delphine Lequin(5), Christelle Dufour(5), François Doz(5), Dominique Ranchère(5), Pascale Varlet(5), Liesbeth Cardoen(5), Delphine Guillemot(4)